Success of Inhaled Corticosteroids in the Treatment of Non-Asthmatic Respiratory Diseases

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Success of Inhaled Corticosteroids in the Treatment of Non-Asthmatic Respiratory Diseases

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 11(3): 210-216.

Author(s): Nazan Cobanoglu.

Affiliation: Near East University Faculty of Medicine, Department of Paediatric Pulmonology, Nicosia, North Cyprus.


Systemic corticosteroids (SCSs) have been widely used to treat various inflammatory respiratory diseases for many years despite the serious complications associated with them. Inhaled corticosteroids (ICSs) have been developed to reduce the harmful adverse effects of SCSs. Since their first introduction, ICSs have been used primarily for the treatment of asthma. However, certain individuals including those with chronic obstructive pulmonary disease or croup may respond to the beneficial effects of ICSs. In this review, we discuss the effectiveness of ICSs in the treatment of non-asthmatic inflammatory respiratory diseases in paediatric and adult populations.


Adult, children, effectiveness, inflammation, inhaled corticosteroids, non-asthmatic respiratory diseases.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 3
First Page: 210
Last Page: 216
Page Count: 7
DOI: 10.2174/1871523011202030210
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science